http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109197882-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P5-00 |
| filingDate | 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109197882-B |
| titleOfInvention | Emamectin benzoate emulsion B2a/B2B and preparation method thereof |
| abstract | The invention provides an emamectin benzoate B2a/B2B benzoate emulsion which comprises an active ingredient emamectin benzoate B2a/B2B, a solvent, a cosolvent, an emulsifier, an anti-photolysis agent and the like. The emamectin benzoate B2a/B2B emulsion prepared by the invention has the advantages of large content range, high stability, low decomposition rate, light resistance and the like. |
| priorityDate | 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.